Antibody Drug Conjugate Therapeutics Market | 2021 Global Industry Analysis by Covid-19 Impact On Healthcare Sector, Business with Forecast to 2027

(The Express Wire via Comtex)

Growing prevalence of cancer is expected to be the major driver for the global “antibody drug conjugate therapeutics” market growth till 2026. According to the International Agency for Research on Cancer (IARC), in 2018, there were 18.1 million new cancer cases and deaths caused by cancer were estimated to be around 9.6 million. By 2030, these deaths are projected to reach 13 million, as per IARC estimates. The World Health Organization (WHO) predicts that new cancer cases will rise by 69% every year till 2030, causing a spike in the demand for antibody drug conjugate (ADC) therapeutics. The global antibody drug conjugate therapeutics market size will enlarge as a result.

Leading Players operating in the Antibody Drug Conjugate Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Bayer AG
  • Pfizer Inc.
  • Hoffman-Le Roche Ltd
  • Seattle Genetics Inc.
  • ImmunoGen Inc.
  • Genentech, Inc.
  • Synthon Holding B.V.

Rising Incidence Rate of Chronic Diseases to Bolster Market Growth

The global antibody drug conjugate therapeutics market is poised to witness impressive growth in the coming decade as chronic diseases become commonplace worldwide. According to the WHO, deaths attributable to chronic diseases will 73% of all deaths and these diseases will be responsible for 60% of the global disease burden by 2020. The most widespread chronic diseases, the WHO states, will be cancer, type-2 diabetes, COPD, and cardiovascular diseases. This will result in a sharp rise in demand for ADCs and accelerate the global antibody drug conjugate therapeutics market revenue in the forecast period.

For more information in the analysis of this report, visit:

Increase in the Number of Breast Cancer Cases to Aid the Market

WHO figures reveal that breast cancer is one of the leading cancer deaths among women, affecting nearly 2.1 million women each year. In 2019, breast cancer killed around 627,000 women, according to the WHO, and the incidence rate of the disease is rising every year. This bodes well for the global antibody drug conjugates market size which will experience considerable expansion during the forecast period.

Antibody Drug Conjugate Therapeutics Market Segmentation:

  • By Mechanism of Action
    • HER2 Antibodies
    • CD30 Antibodies
    • Anti-CD33 Antibody
    • CD22 Antibody
  • By Disease Indication
    • Blood cancer
    • Breast Cancer
    • Ovarian Cancer
    • Lung Cancer
    • Brain Tumor
    • Others
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • By Geography
    • North America (USA and Canada)
    • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
    • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
    • Latin America (Brazil, Mexico and Rest of Latin America)
    • Middle East and Africa (South Africa, GCC and Rest of the Middle East and Africa)

Have Any Query? Ask Our Experts:

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Antibody Drug Conjugate Therapeutics Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Antibody Drug Conjugate Therapeutics Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]


Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Antibody Drug Conjugate Therapeutics Market | 2021 Global Industry Analysis by Covid-19 Impact On Healthcare Sector, Business with Forecast to 2027

comtex tracking